Summary
- Current Price
- As of today, MIRM price is $90.56, up +2.32% in the most recent trading session on
- Current Price All-Time High
- MIRM price is currently -17.13% below its historical high of $109.28 set on
- Market Cap
- MIRM current market cap is $5B, up +135.30% over the past 365 days
- PE Ratio
- MIRM PE ratio is unknown
- Revenue
- MIRM current annual revenue is $521.31M, up +54.74% year-over-year
- Next Earnings
- The next earnings release for MIRM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Mirum Pharmaceuticals, Inc. |
| Ticker | NASDAQ: MIRM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mirumpharma.com |
| Employees | 334 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $90.56 | |
| Price, 1D Change | +2.32% | |
| $5B | ||
| - | ||
| - | ||
| 0.78 | ||
| $521M | ||
| Revenue, 1Y Change | +54.74% | |
| -$0.47 | ||
| EPS, 1Y Change | +74.85% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.47 | ||
| EPS Estimate | N/A | -$1.82 |
| EPS Est. Change | N/A | -291.06% |
| $521.31M | ||
| Revenue Estimate | N/A | $644.90M |
| Revenue Est. Change | N/A | +23.71% |
| Current Price | $90.56 | |
| Price Target | - | $128.00 |
| Price Tgt. Change | - | +41.34% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.42 | -$1.85 | -30.13% | |
| -$0.26 | -$0.47 | -76.02% | |
| -$1.82 | N/A | -291.06% | |
| -$0.11 | N/A | +76.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $334.50M | $336.89M | +0.71% | |
| $515.52M | $521.31M | +1.12% | |
| $644.90M | N/A | +23.71% | |
| $786.48M | N/A | +50.86% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $90.56 | |
| $73.30 | ||
| SMA 200 vs Price | -19.06% | |
| $96.02 | ||
| SMA 50 vs Price | +6.03% | |
| 0.78 | ||
| $4.45 | ||
| 42.27 | ||
| 45.77% | ||
| 43.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $521.31M | ||
| -$0.47 | ||
| $420.73M | ||
| 80.71% | ||
| -$22.14M | ||
| -4.25% | ||
| -$23.36M | ||
| -4.48% | ||
| $2.11M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.02 | ||
| 2.67 | ||
| 2.55 | ||
| - | ||
| 4 | ||
| 6.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 10.40 | ||
| 17.23 | ||
| 2,542.15 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $314.69M | ||
| $383.33M | ||
| $842.81M | ||
| $549.68M | ||
| $528.12M | ||
| $205.80M | ||
| $319.45M | ||
| $2.14M | ||
| $9.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $544.68M | ||
| $442.86M | ||
| $100.58M | ||
| $0.00 | ||
| $24.24M | ||
| $0.00 | ||
| $1.94M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $55.83M | ||
| -$23.95M | ||
| $40.14M | ||
| $954.00K | ||
| $54.87M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| TD Cowen | → | |
| Stifel | → | |
| RBC Capital | → | |
| Leerink Partners | → | |
| Citizens | → | |
| RBC Capital | ||
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with MIRM
FAQ
What is the ticker symbol for Mirum Pharmaceuticals, Inc.?
The ticker symbol for Mirum Pharmaceuticals, Inc. is NASDAQ:MIRM
Does Mirum Pharmaceuticals, Inc. pay dividends?
No, Mirum Pharmaceuticals, Inc. does not pay dividends
What sector is Mirum Pharmaceuticals, Inc. in?
Mirum Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Mirum Pharmaceuticals, Inc. in?
Mirum Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Mirum Pharmaceuticals, Inc. based in?
Mirum Pharmaceuticals, Inc. is headquartered in United States
When did Mirum Pharmaceuticals, Inc. go public?
Mirum Pharmaceuticals, Inc. initial public offering (IPO) was on July 18, 2019
Is Mirum Pharmaceuticals, Inc. in the S&P 500?
No, Mirum Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Mirum Pharmaceuticals, Inc. in the NASDAQ 100?
No, Mirum Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Mirum Pharmaceuticals, Inc. in the Dow Jones?
No, Mirum Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Mirum Pharmaceuticals, Inc. last earnings report?
Mirum Pharmaceuticals, Inc.'s most recent earnings report was on February 25, 2026
When does Mirum Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Mirum Pharmaceuticals, Inc. is May 6, 2026
Data Sources & References
- MIRM Official Website www.mirumpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1759425/000175942526000013/0001759425-26-000013-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1759425/000175942526000013/0001759425-26-000013-index.htm
- MIRM Profile on Yahoo Finance finance.yahoo.com/quote/MIRM
- MIRM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mirm